by Laya Kiani | Jul 11, 2024
Intellectual property (IP) rights in regenerative medicine (RM) are crucial for sparking innovation and staying ahead in a competitive market. Protecting inventions through patents and other IP rights encourages investment by giving inventors exclusive market rights....
by Peace Chukwu | Jul 4, 2024
Cancer remains the second leading cause of death worldwide. The Canadian Cancer Society estimates about 247,100 new cancer cases and 88,100 cancer deaths in Canada in 2024. Ten million deaths worldwide have been estimated to have been caused by cancer in 2020. This...
by Stacey Johnson | Jun 28, 2024
As June comes to an end, so does Pride Month in Canada. In 12 years of blogging for Signals, I realize I have never covered the topic of STEM (science, technology, engineering and mathematics) and Pride, although I have written about Equity, Diversity and Inclusion...
by Lyla El-Fayomi | Jun 18, 2024
“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. Throughout the past month, I’ve spotted some notable trends emerging in the...
by Laine Bodnar | Jun 12, 2024
Have you wondered how many cell and gene therapies (CGTs) have been approved in Canada? So did I. To track the number down, I first turned to my trusty internet search engine with hopes that a list of Health Canada-approved CGTs would already exist online. Notably, it...
by Don Gibbons | May 28, 2024
Spinal cord injury (SCI) seemed like a logical first target for pluripotent stem cell therapy. In many cases a discrete lesion blocks the brain’s nerve signals from reaching the muscles or other tissues they are supposed to instruct. The solution: turn stem cells into...
by Lyla El-Fayomi | May 23, 2024
“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. I’ve gone slightly longer form with this month’s edition, as I found that...
by Medicine by Design | May 13, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
by Medicine by Design | May 6, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
Comments